GHRP‑2 5mg (Pralmorelin) is a hexapeptide growth hormone secretagogue used by researchers to study ghrelin receptor activation and its impact on GH release pathways. Its activity profile makes it well suited to controlled investigations of receptor binding, secretory pulses, and desensitisation phenomena.

In vitro and ex vivo models commonly employ GHRP‑2 to contrast signalling behaviour with other secretagogues or GHRH analogues in our range, helping to map the broader architecture of the growth hormone axis. The 5mg vial size provides practical flexibility for exploratory work, binding assays, and method development.

All batches are produced for research use with verifiable testing available on request, aligning with the expectations of serious endocrine research programmes.

Disclaimer: For scientific research use only. Not for human or animal use or consumption.